Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

SUMO3 inhibits USP25. 2 / 2

| 2

➶

reach

"To clarify whether SUMO2 can competitively block interaction of the Usp25 UBR with ubiquitin substrates, we carried out NMR competition experiments."

28538147

➶

reach

"All these data suggest that SUMO2 negatively regulates the proteolytic activity of Usp25 FL."

28538147

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...